Learn more about clinical trials

Clinical Trials for People with Metastatic Breast Cancer

Read our blog, How Do You Thank Someone for Time.

Many new treatments for metastatic breast cancer are under study. Most of these are drug therapies.

Why should I consider joining a clinical trial?

A clinical trial offers you the chance to try a new treatment and possibly benefit from it. Learning whether a new drug is better than standard treatment can also help others.

Findings from clinical trials determine whether or not new treatments will become a part of the standard of care for metastatic breast cancer. Some treatments may even go on to be used to treat early-stage breast cancer or other types of cancer.

Some clinical trials compare a new treatment to a standard treatment. So, not everyone in the trial gets the new treatment. However, even those who don’t get the new treatment still get the standard treatment, just as they would if they weren’t in the trial.

We encourage you to talk with your oncologist and consider joining clinical trial if there is one right for you. Remember, like all aspects of cancer care, the decision to join a clinical trial is a personal one. Even if you decide not to join a clinical trial now, it doesn’t mean you can’t join one later if you’re eligible.

Learn more about clinical trials, including how to enroll and the informed consent process.

Find a list of questions about clinical trials you may want to ask your health care provider.

Learn what Komen is doing to help people find and participate in breast cancer clinical trials, including trials supported by Komen.

Lajos Pusztai, M.D., D. Phil.
Komen Scholar

“Clinical trials provide a chance to receive tomorrow’s therapies today.”

When to consider joining a clinical trial

If you’ve been diagnosed with metastatic breast cancer, consider joining a clinical trial before starting treatment for metastatic breast cancer, when your oncologist is considering changing treatments, or when there are limited treatment options.

Will I get a placebo?

A placebo is an inactive substance sometimes used to have a comparison to a drug in a clinical trial. Some people call this a “sugar pill.”

In breast cancer treatment clinical trials, you never get a placebo instead of standard treatment. However, sometimes, you may get the standard treatment plus a placebo rather than the standard treatment plus the new treatment that’s being studied.

Most often, you’ll get either the new treatment or the standard treatment. So, even if you don’t get the new drug, your breast cancer will be treated the same as if you weren’t in the trial.

Where to find a clinical trial

Some clinical trials are done in one, or only a few, medical centers. Others are done in many places across the country.

There may not be a clinical trial that’s right for you in your area. So, you may have to travel if you want to join.

If your medical center doesn’t offer clinical trials, your oncologist can refer you to a cancer center that does.

Susan G. Komen® Patient Care Center

If you or a loved one needs information or resources about clinical trials, the Patient Care Center can help. Contact the Komen Breast Care Helpline at 1-877-465-6636 or email clinicaltrialinfo@komen.org.

The Patient Care Center navigators offer breast cancer clinical trial education and support, such as:

  • Knowing when to consider a trial
  • How to find a trial
  • How to decide which trial is best for you
  • What to expect during a trial
  • Information about clinical trial resources

Metastatic Trial Search

 Expanded Access

Susan G. Komen® supported the Reagan-Udall Foundation and the Food and Drug Administration (FDA) in the development of the Expanded Access Navigator website.

Expanded Access (EA) is also known as “compassionate use.” It gives patients access to drugs before they have FDA approval. This may be needed when patients have no other treatment options and are not eligible for (or unable to participate in) a clinical trial.

The EA Navigator tool has information and resources to help patients and their doctors more easily access information that could impact treatment decisions. The EA Navigator explains what EA is, who may be eligible, how the request process works, as well as the regulatory and policy issues around EA.

The EA Navigator also contains pharmaceutical companies’ EA policies. The open EA programs are listed on the National Institutes of Health’s clinical trials website, www.clinicaltrials.gov.

 Updated 03/26/24



Educational Resources

Metastatic Breast Cancer

Research Fast Facts

Need Help or
More Information?

1-877 GO KOMEN